SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-06-017215
Filing Date
2006-03-16
Accepted
2006-03-16 13:25:50
Documents
10
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-2121_110k.htm 10-K 1331854
2 MATERIAL CONTRACTS a06-2121_1ex10d35.htm EX-10.35 418891
3 MATERIAL CONTRACTS a06-2121_1ex10d36.htm EX-10.36 232603
4 MATERIAL CONTRACTS a06-2121_1ex10d37.htm EX-10.37 172658
5 CONSENTS OF EXPERTS AND COUNSEL a06-2121_1ex23d1.htm EX-23.1 4238
6 302 CERTIFICATION a06-2121_1ex31d1.htm EX-31.1 11402
7 302 CERTIFICATION a06-2121_1ex31d2.htm EX-31.2 11389
8 906 CERTIFICATION a06-2121_1ex32d1.htm EX-32.1 5581
9 906 CERTIFICATION a06-2121_1ex32d2.htm EX-32.2 5585
10 GRAPHIC g21211kb01i001.jpg GRAPHIC 694
  Complete submission text file 0001104659-06-017215.txt   2196738
Mailing Address 22026 20TH AVENUE SE, SUITE 102 BOTHELL WA 98021
Business Address 22026 2OTH AVE SE STE 102 BOTHELL WA 98021 2064879500
SONUS PHARMACEUTICALS INC (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21243 | Film No.: 06691001
SIC: 2835 In Vitro & In Vivo Diagnostic Substances